| 000 | 01557 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515145028.0 | ||
| 264 | 0 | _c20081118 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a1535-7228 | ||
| 024 | 7 |
_a10.1176/appi.ajp.2008.08030334 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDrake, Robert | |
| 245 | 0 | 0 |
_aWhat explains the diffusion of treatments for mental illness? _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cNov 2008 |
||
| 300 |
_a1385-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCost-Benefit Analysis _xtrends |
| 650 | 0 | 4 | _aDiffusion of Innovation |
| 650 | 0 | 4 |
_aDrug Costs _xtrends |
| 650 | 0 | 4 |
_aEvidence-Based Medicine _xeconomics |
| 650 | 0 | 4 | _aForecasting |
| 650 | 0 | 4 |
_aHealth Policy _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance Coverage _xeconomics |
| 650 | 0 | 4 |
_aMarketing of Health Services _xeconomics |
| 650 | 0 | 4 |
_aMedicaid _xeconomics |
| 650 | 0 | 4 |
_aMental Disorders _xdiagnosis |
| 650 | 0 | 4 | _aPrejudice |
| 650 | 0 | 4 |
_aQuality Assurance, Health Care _xeconomics |
| 650 | 0 | 4 | _aResearch |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aSkinner, Jonathan | |
| 700 | 1 | _aGoldman, Howard H | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 165 _gno. 11 _gp. 1385-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/appi.ajp.2008.08030334 _zAvailable from publisher's website |
| 999 |
_c18442563 _d18442563 |
||